Albanin A is primarily studied for its potential anti-inflammatory and antioxidant properties. It has shown inhibitory effects on pro-inflammatory cytokines, making it a candidate for research in inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, its antioxidant activity suggests possible use in reducing oxidative stress-related damage, which is linked to neurodegenerative conditions like Alzheimer's and Parkinson's disease. Albanin A also exhibits moderate antimicrobial activity, particularly against certain Gram-positive bacteria, indicating potential as a lead compound in developing new antimicrobial agents. Ongoing studies are exploring its role in cancer prevention due to its ability to induce apoptosis in some tumor cell lines.